The ERBB receptor inhibitor dacomitinib suppresses proliferation and invasion of pancreatic ductal adenocarcinoma cells




Majid Momeny, Fatemeh Esmaeili, Sepideh Hamzehlou, Hassan Yousefi, Sepehr Javadikooshesh, Vasimeh Vahdatirad, Zivar Alishahi, Seyedeh H. Mousavipak, Davood Bashash, Ahmad R. Dehpour, Seyyed M. Tavangar, Javad Tavakkoly-Bazzaz, Peiman Haddad, Farzaneh Kordbacheh, Kamran Alimoghaddam, Ardeshir Ghavamzadeh, Seyed H. Ghaffari

PublisherSpringer Netherlands

2019

Cellular Oncology

Cellular Oncology

42

4

491

504

14

2211-3428

2211-3436

DOIhttps://doi.org/10.1007/s13402-019-00448-w




Last updated on 2024-26-11 at 22:54